We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+10%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$44.5B
AUM Growth
-$1.18B
(-2.6%)
Cap. Flow
-$4.15B
Cap. Flow
% of AUM
-9.34%
Top 10 Holdings %
Top 10 Hldgs %
9.83%
Holding
3,927
New
652
Increased
690
Reduced
847
Closed
1,056
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$309M |
| 2 |
ExxonMobil
XOM
|
+$302M |
| 3 |
Amazon
AMZN
|
+$291M |
| 4 |
Citigroup
C
|
+$253M |
| 5 |
Shopify
SHOP
|
+$238M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Humana
HUM
|
+$383M |
| 2 |
Johnson & Johnson
JNJ
|
+$312M |
| 3 |
JPMorgan Chase
JPM
|
+$285M |
| 4 |
AT&T
T
|
+$191M |
| 5 |
Dollar General
DG
|
+$187M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.63% |
| 2 | Financials | 15.61% |
| 3 | Technology | 14.28% |
| 4 | Consumer Discretionary | 13.21% |
| 5 | Industrials | 5.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
276
PUT
JPMorgan Chase
JPM
$939B
| $35.3M | 0.08% |
262,900
+176,100
| +203% | +$22.3M |
|
277
Tesla
TSLA
$1.24T
| $35.2M | 0.08% |
286,129
-241,288
| -46% | -$45.7M |
|
278
Allegion
ALLE
$13B
| $35.2M | 0.08% |
334,572
+217,722
| +186% | +$22.7M |
|
|
DOC
279
DELISTED
PHYSICIANS REALTY TRUST
DOC
| $35M | 0.08% |
+2,417,937
| New | +$35.1M |
|
280
Pfizer
PFE
$140B
| $34.8M | 0.08% |
679,674
-3,351,413
| -83% | -$161M |
|
281
Dutch Bros
BROS
$8.78B
| $34.8M | 0.08% |
1,234,094
-445,570
| -27% | -$14.7M |
|
282
Baidu
BIDU
$35.8B
| $34.7M | 0.08% |
303,155
+279,160
| +1,163% | +$28.5M |
|
283
CALL
State Street Energy Select Sector SPDR ETF
XLE
$39.5B
| $34.6M | 0.08% |
791,000
+437,000
| +123% | +$19M |
|
284
Gentex
GNTX
$4.88B
| $34.5M | 0.08% |
1,265,553
+169,193
| +15% | +$4.51M |
|
285
Synchrony
SYF
$23.7B
| $34.5M | 0.08% |
1,049,846
-529,827
| -34% | -$18.1M |
|
286
PUT
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
$45.8B
| $34.5M | 0.08% |
104,100
+85,800
| +469% | +$27.9M |
|
287
CALL
State Street Financial Select Sector SPDR ETF
XLF
$55.6B
| $34.4M | 0.08% |
1,005,600
-373,400
| -27% | -$12.6M |
|
288
Realty Income
O
$61.2B
| $34.1M | 0.08% |
537,154
-647,578
| -55% | -$40.2M |
|
289
Ecopetrol
EC
$32.9B
| $33.8M | 0.08% |
3,232,841
+1,983,223
| +159% | +$19.3M |
|
290
PUT
Intel
INTC
$466B
| $33.8M | 0.08% |
1,279,100
+199,000
| +18% | +$5.53M |
|
291
Knight Transportation
KNX
$11.8B
| $33.8M | 0.08% |
+644,723
| New | +$33.3M |
|
292
PUT
Berkshire Hathaway Class B
BRK.B
$1.07T
| $33.7M | 0.08% |
+109,200
| New | +$32.4M |
|
|
SWIR
293
DELISTED
Sierra Wireless
SWIR
| $33.7M | 0.08% |
+1,160,771
| New | +$34.1M |
|
294
Avery Dennison
AVY
$12.3B
| $33.6M | 0.08% |
+185,852
| New | +$33.1M |
|
295
HealthEquity
HQY
$7.91B
| $33.5M | 0.08% |
542,897
+156,495
| +41% | +$10.5M |
|
296
iShares TIPS Bond ETF
TIP
$14.5B
| $33.4M | 0.08% |
314,088
+269,900
| +611% | +$28.8M |
|
297
Zurn Elkay Water Solutions
ZWS
$8.07B
| $33.1M | 0.07% |
1,563,848
-179,017
| -10% | -$4.23M |
|
298
DoubleVerify
DV
$1.62B
| $33M | 0.07% |
1,501,085
+1,160,185
| +340% | +$30.2M |
|
299
Vistra
VST
$55.1B
| $32.9M | 0.07% |
1,418,807
+681,560
| +92% | +$15.8M |
|
300
Qorvo
QRVO
$7.63B
| $32.5M | 0.07% |
358,118
+184,980
| +107% | +$16.7M |
|
Similar funds
Marshall Wace's Q4 2022 Portfolio in Review
As of Q4 2022, Marshall Wace held 3,927 positions worth $44.5B, down 2.6% from $45.6B the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.
Marshall Wace withdrew a net $4.15B in Q4 2022, closing 1,056 positions and reducing 847 holdings. Its most notable exit was Humana, an estimated $383M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 15% a quarter earlier, followed by Financials and Technology.
Against the trend, Marshall Wace opened a new position in Elevance Health worth $188M.
- Marshall Wace's largest Q4 2022 buy was Elevance Health: 366,649 shares worth $188M.
- Marshall Wace added most to Biogen in Q4 2022, an estimated $309M increase.
- Marshall Wace's biggest Q4 2022 reduction was Johnson & Johnson, cutting an estimated $312M.
- Marshall Wace fully exited Humana in Q4 2022, selling an estimated $383M.
- Marshall Wace's ten largest holdings make up 9.8% of its $44.5B portfolio in Q4 2022.
- Marshall Wace opened 652 new positions and closed 1,056 in Q4 2022.
- Marshall Wace's portfolio value fell 2.6% quarter-over-quarter to $44.5B.
Based on Marshall Wace's 13F filing for Q4 2022, filed 14 Feb 2023.